Corneal perforation in ocular graft-versus-host disease

Cathy Y Zhang1, Asim V Farooq2, George J Harocopos1,3

  • 1Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, 660 S Euclid Ave, St. Louis, MO, 63110, United States.

Insights

Corneal perforation after ocular graft-versus-host disease (GVHD) is a serious complication. A significant time gap exists between ocular GVHD diagnosis and perforation, offering a window for preventative strategies.

Area of Science:

  • Ophthalmology
  • Hematology
  • Immunology

Background:

  • Ocular graft-versus-host disease (GVHD) is a rare complication following hematopoietic stem cell transplant (HSCT).
  • Corneal perforation is a severe, vision-threatening manifestation of ocular GVHD, with limited understanding of its clinical progression.

Purpose of the Study:

  • To investigate the clinical course and histopathologic findings in patients who developed corneal perforation secondary to ocular GVHD.
  • To identify potential risk factors and timing associated with corneal perforation in ocular GVHD patients.

Main Methods:

  • Retrospective case series involving 14 patients from four academic centers.
  • Analysis of patient demographics, HSCT details, ocular GVHD timeline, visual acuity, interventions, and histopathology.
  • Correlating clinical presentation with histopathologic findings of corneal perforation.

Main Results:

  • The average age at HSCT was 47 years, with most patients being male and Caucasian.
  • Mean interval from HSCT to ocular GVHD diagnosis was 9.5 months, and to corneal perforation was 37 months.
  • All patients experienced poor visual outcomes despite aggressive management, including corneal gluing and keratoplasty; histopathology suggested sterile corneal melt.

Conclusions:

  • An extended interval between ocular GVHD diagnosis and corneal perforation was observed.
  • This interval presents a critical opportunity for intervention to prevent perforation.
  • Further research is needed to identify high-risk patients and optimize preventive measures.
Abstract